A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

Clinical trial NCT07511114 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07511114
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

DLBCL - Diffuse Large B Cell Lymphoma Double Expressor Lymphoma

Start date: 2026-03-31
Primary completion: 2028-03-31
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.